Navitus Learning & Development Team Named Top 10 by OnCon Icon Awards
We’re thrilled to share that we’ve been recognized for having one of the Top 10 Learning and Development (L&D) Teams by the prestigious OnConferences (OnCon) Icon Awards.
The OnCon Icon Awards celebrate outstanding achievements of top organizations and teams worldwide. This recognition is determined through peer and community voting. Voters are instructed to select teams they have seen make a significant impact on their own organization or within the broader industry, contribute to their professional community through thought leadership, drive innovation and demonstrate exceptional leadership.

Our team embodies all of these qualities: consistently pushing boundaries to create learning programs that empower associates, foster growth and build a culture of continuous development.
For current associates, this award reinforces the value of the learning journey you’re a part of. For prospective talent, it’s a signal that when you join us, you’re stepping into an environment that invests in your growth and success.
We’re proud of this achievement and even more excited about what’s ahead.
Learn more about careers at Navitus: www.navitus.com/careers.
For more information about the OnCon Icon Awards and to view the full list of winners, please visit https://www.onconferences.com/awards.
About OnConferences
OnConferences is a leading organization that connects top professionals across various industries, promoting collaboration, innovation and thought leadership. Through conferences, awards and networking opportunities, OnConferences provides a platform for executives and organizations to exchange insights, fostering growth and development within their respective fields.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
CLARITY FOR ACTION
Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download
Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.




